Literature DB >> 8318418

Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

U Elsässer-Beile1, S von Kleist, W Sauther, H Gallati, J S Mönting.   

Abstract

The production of the cytokines IFN-gamma, IL-1-alpha, IL-2 and TNF-alpha was investigated in mitogen-stimulated, whole blood cell culture from 239 untreated patients with primary gynaecological carcinomas (breast, cervix, ovary, endometrium), and 191 healthy female controls. The cytokines were measured in the 4-day post-induction supernatants by a sensitive enzymoimmunological assay. In the blood cell cultures of all four groups of cancer patients, significantly lower values of IFN-gamma (P < or = 0.001), IL-2 (P < or = 0.01) and IL-1 alpha (P < or = 0.01) were found as compared to the controls, although lymphocyte and monocyte counts were almost identical. Grouping the tumour patients into different clinical stages we could show in the four groups of carcinomas a gradual depression of the cytokine production according to growing tumour burden.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318418      PMCID: PMC1968320          DOI: 10.1038/bjc.1993.282

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers.

Authors:  P M Bolton; A M Mander; J M Davidson; S L James; R G Newcombe; L E Hughes
Journal:  Br Med J       Date:  1975-07-05

2.  Immunologic reactivity in patients with primary operable breast cancer.

Authors:  H J Wanebo; H T Thaler; J A Hansen; P P Rosen; G F Robbins; J A Urban; H F Oettgen; R A Good
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

3.  Cell-mediated immune status of colon cancer patients: evaluation by dermal antigen testing, measurment of lymphocyte stimulation and counts of peripheral blood rosette-forming cells.

Authors:  J T Evans; M H Goldrosen; J Minowada; J Howell; A Mittelman; T M Chu; E D Holyoke
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

5.  Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.

Authors:  A Rey; B Klein; D Zagury; C Thierry; B Serrou
Journal:  Immunol Lett       Date:  1983-03       Impact factor: 3.685

6.  Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production.

Authors:  L B Santos; F T Yamada; M A Scheinberg
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

7.  The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens.

Authors:  J H Dean; R Connor; R B Herberman; J Silva; J L McCoy; R K Oldham
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

8.  Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma.

Authors:  U Elsässer-Beile; S von Kleist; W Stähle; C Schurhammer-Fuhrmann; J S Mönting; H Gallati
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

9.  Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.

Authors:  H J Wanebo; R Pace; S Hargett; D Katz; J Sando
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

10.  Detection of impaired mitogen responses in autologous whole blood of cancer patients using an optimized method of lymphocyte stimulation.

Authors:  D Fritze; P Dystant
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

View more
  4 in total

1.  Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.

Authors:  Stephania Libreros; Ramon Garcia-Areas; Yoshimi Shibata; Roberto Carrio; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

2.  Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.

Authors:  N Jacobs; S L Giannini; J Doyen; A Baptista; M Moutschen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  Significant impairment in immune recovery after cancer treatment.

Authors:  Duck-Hee Kang; Michael T Weaver; Na-Jin Park; Barbara Smith; Traci McArdle; John Carpenter
Journal:  Nurs Res       Date:  2009 Mar-Apr       Impact factor: 2.381

4.  Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

Authors:  S Della Bella; M Gennaro; M Vaccari; C Ferraris; S Nicola; A Riva; M Clerici; M Greco; M L Villa
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.